West China Journal of Stomatology

Previous Articles     Next Articles

Study on prohibition of high mobility group chromosomal protein N2 against human oral squamous cell carcinoma in vitro

 Dong Xiaoqian, Liu Xiqian, Zhang Yonghong, Zhang Ping, Lu Libing, Li Xiaoyu, Huang Ping, Feng Yun   

  1. State Key Laboratory of Oral Diseases, Sichuan University, Chengdu 610041, China
  • Online:2013-02-01 Published:2013-02-01

Abstract:

Objective  Take human oral squamous cell carcinoma Tca8113 as experimental model, and study the anti oral squamous cell carcinoma activity of high mobility group chromosomal protein N2(HMGN2) molecule. Methods  Train a large number of recombinant human HMGN2 expression vector Escherichia coli BL21. HMGN2 was expressed under isopropyl-1-thio-β-galactopyranoside(IPTG) induction and purified by B-PER GST Fusion Protein Purification Kit. A variety of concentrations HMGN2 were added to cell culture medium, cells were tested by MTT, Hoechst 33342 fluorescence staining, flow cytometry assay and Western-blot. Results  MTT results proved that HMGN2 could significantly inhibit human oral squamous cell carcinoma Tca8113 growth. Hoechst 33342 fluorescence staining, flow cytometry assay test and Western-blot proved HMGN2 could make Tca8113 cells morphological change, make Tca8113 cells block in S period of cell cycle and strongly promote Tca8113 cells to apoptosis. Conclusion  HMGN2 can promote apoptosis of oral squamous cell carcinoma cells.

Key words: high mobility group chromosomal protein N2, human oral squamous cell carcinoma cell line, apoptosis